Kapoose Creek is harnessing the potential of nature’s uncharted chemistry and AI’s untapped power to reinvent modern drug discovery and address the greatest medical challenges of our time.

Opportunity laying in wait

Exploring even a fraction of nature’s uncharted chemistry has the potential to reshape medicine.

More than


of therapies developed in the last 30 years are derived from nature.

It is estimated that less than


of the natural world’s chemistry has been characterized to date.

An ecosystem ripe for therapeutic discovery

Our chemical library is rooted in a land of uninterrupted evolution

We are exploring untapped natural ecosystems to find the next generation of world-changing medicines hidden in wild fungi. Our first research site, Kapoose Creek, located on the northwest coast of Vancouver Island, was part of a rare ice-free corridor during the last ice age. As a result, this land has a rich ecosystem and unique mycological biodiversity.

Our unEarth Rx discovery platform is purpose-built to overcome the historical limitations of natural product drug discovery.

It empowers us to:
  • Access never-before-seen natural chemistry
  • Screen compounds for diverse therapeutic activities in parallel
  • Rapidly identify and characterize bioactive hit compounds
  • Create remarkable new chemistry optimized for bioactivity
  • Produce rare chemistry at scale for downstream R&D

Our integrated platform dramatically accelerates the timeline to advance from screen to lead

unEarth Rx Technology Stack

We gain access to the inaccessible, clearing a major hurdle in natural product drug discovery

  • We are building synthetic biology systems that enable us to circumvent the limitations of nature and efficiently produce lead molecules at scale for development and production.
  • We leverage a proprietary expression chassis built on soil bacteria that greatly exceeds the output and efficiency of other synthetic biology approaches.
  • Our optimized methods drastically increase scale and reduce the cost of obtaining fungal molecules.

Alliances that deepen our scientific capabilities

Our partnerships with McMaster University amplify our resources with some of the world’s top scientists, state-of-the-art equipment, drug discovery platforms, robotic automation, artificial intelligence, natural product screening, and more.

The team

A seasoned group of entrepreneurs, business leaders and scientists

Dr. Eric Brown

Chief Executive Officer

Jonathan Jackson

Chief Operating Officer

Dr. Geordie Stewart

Chief Business Development Officer

Dr. Michael Frankel

Chief Medical Advisor

Dr. Tomasz Czarny

VP Research and Development

Brandon Walle

Director, Biology

Janet De Gouw

Research Lead, Biology

Valjean Trotman

Regulatory and Quality Advisor

The Board & Scientific Advisors

Sam Feldman

Founder and Chairman

Dr. Gerry Wright

McMaster University

Paul Petrelli

General Manager, 
Jazz Pharmaceuticals

Dr. Leah Cowen

University of Toronto

Norma Biln

CEO, Augurex Life Sciences

Dr. Max Cynader

University Of British Columbia

Dr. Armand Balboni

Director, Bloom Burton & Co Investment Bank

Dr. Matthew Miller

McMaster University

Want to get in touch? Reach out to the Kapoose Creek team.

Investor information available upon request.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

Kapoose Creek News

Press Release

Venerable Ventures to Acquire Kapoose Creek Wellness

Sep 08, 2021